Time to Begin a New Chapter and Expand Rotavirus Immunization
- 18 June 2014
- journal article
- editorial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 59 (7) , 982-986
Abstract
Rotavirus immunization has been limited to young infants owing to intussusception events noted with a prior rotavirus vaccine, RotaShield. Dramatic declines occurred in rotavirus-related disease beginning in 2008 after implementation of rotavirus vaccination in young infants. These declines occurred in vaccinated children and unvaccinated children and adults (through indirect protection). Despite these declines, reasons for concern exist about the durability of these declines. These reasons include an incomplete immune response that is not lifelong and rotavirus immunization completion rates that have plateaued at <70% of eligible children. Current rotavirus infant vaccination strategies and indirect protection of unvaccinated children will result in a large population of immunologically susceptible persons who will be at risk of rotavirus disease. Expansion of US rotavirus vaccination outside the current Advisory Committee on Immunization Practices recommended immunization age limits would provide important benefits that outweigh risk related to intussusception.Keywords
This publication has 36 references indexed in Scilit:
- Gastroenteritis Hospitalizations in Older Children and Adults in the United States Before and After Implementation of Infant Rotavirus VaccinationJAMA, 2013
- Indirect Protection of Adults From Rotavirus by Pediatric Rotavirus VaccinationClinical Infectious Diseases, 2013
- Infant Rotavirus Vaccination May Provide Indirect Protection to Older Children and Adults in the United StatesThe Journal of Infectious Diseases, 2011
- Direct and Indirect Effects of Rotavirus Vaccination Upon Childhood Hospitalizations in 3 US Counties, 2006–2009Clinical Infectious Diseases, 2011
- Active, Population-Based Surveillance for Severe Rotavirus Gastroenteritis in Children in the United StatesPediatrics, 2008
- Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled studyThe Lancet, 2007
- Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus VaccineNew England Journal of Medicine, 2006
- Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus GastroenteritisNew England Journal of Medicine, 2006
- Rotavirus infection in adultsThe Lancet Infectious Diseases, 2004
- Rotavirus Infection in Infants as Protection against Subsequent InfectionsNew England Journal of Medicine, 1996